5071 - 5080 of 6171 Results
Title
Year
- Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer’s Disease With Aggression or Agitation: The CitAD Randomized Clinical Trial2016OPENTitle: Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer’s Disease With Aggression or Agitation: The CitAD Randomized Clinical TrialJournal Name: American Journal of PsychiatryPublisher: American Psychiatric Association PublishingVol: 173Issue #: 5Start Page: 465End Page: 472Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1176/appi.ajp.2015.15050648Best OA location URL: https://ajp.psychiatryonline.org/doi/pdf/10.1176/appi.ajp.2015.15050648Citation Count: 86
- Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats2016OPENTitle: Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in ratsJournal Name: NeurosciencePublisher: Elsevier BVVol: 318Issue #:Start Page: 157End Page: 165Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2016.01.020Best OA location URL: https://europepmc.org/articles/pmc4753102?pdf=renderCitation Count: 92
-
OPENTitle: Overlap between Parkinson disease and Alzheimer disease in ABCA7 functional variantsJournal Name: Neurology GeneticsPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 2Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxg.0000000000000044Best OA location URL: https://ng.neurology.org/content/nng/2/1/e44.full.pdfCitation Count: 33
- Altered Expression Patterns of Inflammation-Associated and Trophic Molecules in Substantia Nigra and Striatum Brain Samples from Parkinson's Disease, Incidental Lewy Body Disease and Normal Control Cases2016OPENTitle: Altered Expression Patterns of Inflammation-Associated and Trophic Molecules in Substantia Nigra and Striatum Brain Samples from Parkinson's Disease, Incidental Lewy Body Disease and Normal Control CasesJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2015.00507Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2015.00507/pdfCitation Count: 34
- Different PD-MCI criteria and risk of dementia in Parkinson’s disease: 4-year longitudinal study2016OPENTitle: Different PD-MCI criteria and risk of dementia in Parkinson’s disease: 4-year longitudinal studyJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 2Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/npjparkd.2015.27Best OA location URL: https://www.nature.com/articles/npjparkd201527.pdfCitation Count: 71
- The IgLON Family Member Negr1 Promotes Neuronal Arborization Acting as Soluble Factor via FGFR22016OPENTitle: The IgLON Family Member Negr1 Promotes Neuronal Arborization Acting as Soluble Factor via FGFR2Journal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2015.00089Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2015.00089/pdfCitation Count: 58
-
OPENTitle: Impairment of PARK14-dependent Ca2+ signalling is a novel determinant of Parkinson’s diseaseJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/ncomms10332Best OA location URL: https://www.nature.com/articles/ncomms10332.pdfCitation Count: 92
- Prevalence of Submandibular Gland Synucleinopathy in Parkinson’s Disease, Dementia with Lewy Bodies and other Lewy Body Disorders2016OPENTitle: Prevalence of Submandibular Gland Synucleinopathy in Parkinson’s Disease, Dementia with Lewy Bodies and other Lewy Body DisordersJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 6Issue #: 1Start Page: 153End Page: 163Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-150680Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5498170Citation Count: 67
- Systems-level neurophysiological state characteristics for drug evaluation in an animal model of levodopa-induced dyskinesia2016OPENTitle: Systems-level neurophysiological state characteristics for drug evaluation in an animal model of levodopa-induced dyskinesiaJournal Name: Journal of NeurophysiologyPublisher: American Physiological SocietyVol: 115Issue #: 3Start Page: 1713End Page: 1729Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1152/jn.00868.2015Best OA location URL: https://portal.research.lu.se/files/27488018/5350550_.pdfCitation Count: 24
- LRRK2 phosphorylates pre-synaptic N-ethylmaleimide sensitive fusion (NSF) protein enhancing its ATPase activity and SNARE complex disassembling rate2016OPENTitle: LRRK2 phosphorylates pre-synaptic N-ethylmaleimide sensitive fusion (NSF) protein enhancing its ATPase activity and SNARE complex disassembling rateJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-015-0066-zBest OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-015-0066-zCitation Count: 164